Loading...
Loading...
Click here if you don’t see subscription options
Voices
Charles C. Camosy is a professor of medical humanities at the Creighton University School of Medicine and holds the Monsignor Curran Fellowship in Moral Theology at St. Joseph Seminary in New York. He is the author of eight books, including, most recently, One Church. 
Arts & CultureBooks
Charles C. Camosy
There is a perception that the hook-up culture is more prevalent than it actually is.
Arts & CultureBooks
Charles C. Camosy
Perhaps the most powerful pro-choice argument rests on the claim that restrictions on abortion do not actually stop abortion from happening—they only make said abortions safer. Biemans devastates the foundations of this argument.
FaithIn All Things
Charles C. Camosy
Naming it “corrosive” and a “dark” sign of contemporary American culture, the U.S. Catholic bishops approved a document this week condemning the production and use of pornography as a mortal sin.
Cecile Richards, president of Planned Parenthood, before Congress
In All Things
Charles C. Camosy
Selling body parts is not the only legal issue, and it may not even be the most important
In All Things
Charles C. Camosy
We should be honest as a culture about the fact that these children are killed not because they are a burden on themselves, but because having a child with Down’s doesn’t meet our expectations.
People with Down syndrome are actually happier than those who are “normal.”
In All Things
Charles C. Camosy
Discouraging abortion as a response to Down syndrome could be an area of agreement for those who otherwise think very differently about abortion.
A MOUSE’S LIFE. A pharmacologist checks the reaction on a hairless mouse after applying drugs for anti- tumor cancer at Natco Research Center in the Indian city of Hyderabad.
Susan KoppCharles C. Camosy
‘Animal abuse? I don’t look at it that way. It’s not testing cosmetics. It’s trying to save my life.”So says Eileen Youtie, a breast cancer patient who, according to a Dec. 14 report from the Associated Press, is paying more than $30,000 to test various chemotherapy dru